Page 16 - Alkermes News Today

Atossa Therapeutics Inc (NASDAQ:ATOS) has appointed Dr. Arezoo Mirad as senior medical director, the clinical biopharmaceutical company announced Monday....

By Sabela Ojea Shares of National Healthcare climbed following news of the company's upcoming inclusion to the S&P SmallCap 600 Index. At 12:40 p.m. EST on...

/PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior...

(BPT) - Sponsored by Alkermes, Inc.

(BPT) - Sponsored by Alkermes, Inc.

StockNews.com upgraded shares of Alkermes (NASDAQ:ALKS – Free Report) from a buy rating to a strong-buy rating in a report published on Sunday morning. Several other research analysts have also weighed in on ALKS. Piper Sandler lowered their price objective on Alkermes from $37.00 to $35.00 and set an overweight rating for the company in […]

Alkermes plc (NASDAQ:ALKS – Get Free Report) fell 3.3% during trading on Tuesday . The company traded as low as $22.22 and last traded at $23.43. 1,183,288 shares were traded during mid-day trading, a decline of 23% from the average session volume of 1,543,203 shares. The stock had previously closed at $24.22. Analyst Ratings Changes […]

Pharmaceuticals in the Environment

Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The

Men are more likely than women to misuse prescription stimulants, new data from a national survey on drug use show.